HALO Precision Diagnostics logo — Precision diagnostics for early disease detection.

HALO Precision Diagnostics

Precision diagnostics for early disease detection.

Founded 2016 United States Menlo Park, United States 180 employees Series B Total: $19.00M Enterprise Software, Health Care +1

General Information

Company Name HALO Precision Diagnostics
Founded Year 2016
Location United States Menlo Park, United States
Founders / Decision Makers
Team member
Employees 180
Industries Enterprise Software, Health Care, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with HALO Precision Diagnostics. To contact HALO Precision Diagnostics, visit halodx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does HALO Precision Diagnostics compare?

A PDF of HALO Precision Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting HALO Precision Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About HALO Precision Diagnostics

**HALO Precision Diagnostics** is a startup that focuses on precision diagnostics for early disease detection with the slogan "Precision diagnostics for early disease detection." Founded in 2019 and headquartered in the United States, HALO Precision Diagnostics aims to change patient lives and outcomes through early detection of leading causes of death using a personalized diagnostic ensemble. The company's approach involves leveraging advanced imaging, genomics, non-invasive liquid biomarkers, and community-based data at scale, combined with deep learning algorithms. This optimization is achieved through the HALO Diagnostics platform, providing rapid, precise, and actionable results. Such results enable life-changing treatments by physicians for their patients. The company's latest funding round was a $19.00M Series B investment on 04 March 2021. The investors in this round included Toba Capital, Zola Global, James Pallotta, Stephen Pomeranz, Bob Reed, Ronnie Lott, Robert Ciardi, Anne Wojcicki, Warren Jenson, and Fred Moll, M.D. HALO Precision Diagnostics operates in the industries of Enterprise Software, Health Care, and Medical Devices.

Business keywords: precision diagnostics, early disease detection, personalized healthcare, genomics, advanced imaging, non-invasive liquid biomarkers, deep learning algorithms, interventional radiology, prostate cancer treatment, breast cancer, MRI, dementia, heart disease, lung disease, neurology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $19.00M 10
Toba Capital, Zola Global +8
04 Mar 2021

HALO Precision Diagnostics Alternatives & Competitors

View All Alternatives
HALO Precision Diagnostics vs

Empowering medical diagnostics with advanced breath screening for early disease detection.

Seed
Health Care, Life Sciences
HALO Precision Diagnostics vs
Hevi AI
Hevi AI Turkey

Medical image based artifical intelligence solutions startup

Seed
29 employees
AI, Health Care
HALO Precision Diagnostics vs
Quantib
Quantib The Netherlands

Supercharge your practice with artificial intelligence

Grant
5 employees
AI, Health Care

FAQ About HALO Precision Diagnostics

Precision diagnostics for early disease detection.
HALO Precision Diagnostics was founded in 2016.
HALO Precision Diagnostics is headquartered in Menlo Park, United States.
HALO Precision Diagnostics operates in Enterprise Software, Health Care and Medical Devices. Its work centres on precision diagnostics, early disease detection, personalized healthcare and genomics.
HALO Precision Diagnostics has approximately 180 employees.
HALO Precision Diagnostics has completed 1 funding round, raising a total of $19.00M. The latest funding stage is Series B.
Top alternatives and competitors to HALO Precision Diagnostics include ANCON Medical, Hevi AI, Quantib, CureMetrix, Optellum. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HALO Precision Diagnostics and ANCON Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HALO Precision Diagnostics, https://bouncewatch.com/company/halo-precision-diagnostics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes